Published August 30, 2024 | Version CC-BY-NC-ND 4.0
Journal article Open

The Viability of Emerging Public and Private Generic Drug Infrastructure in India: An in-vitro Case Study Using Statins as Model Drug

Creators

  • 1. School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar-751003, Odisha, INDIA.

Description

ABSTRACT: The healthcare system has been fundamentally altered by the introduction of generic medications, and their market share continues to rise because these are genuine, dependable, secure, affordable, and accessible to all the needy and poor in society. In this regard, the generic drug industry, which strives for authenticity, affordability, and accessibility, plays a significant role. Using HMG CoA reductase inhibitors (Atorvastatin and Rosuvastatin) as model drugs, the study aimed to determine the viability of the emerging public and private generic drug infrastructure in India, which included Janaushadhi, Dava India, and other assorted companies. The organoleptic properties and official and non-official quality control tests were evaluated. According to the in-vitro dissolution profiles, the Mankind brand of atorvastatin has shown the highest dissolution profile (75.29%), and the Dava India brand of rosuvastatin has the maximum drug release (97.26%) in one hour release. The Peppas model best explained the drug release model, which inferred the release profile to be diffusion-specific. The compatibility analysis of the tablet formulation has been shown through FTIR studies. These results concluded that public generic drugs are as effective as private generic drugs, and patients can easily take the cost-effective brand of medication.

Files

E404504050824.pdf

Files (680.4 kB)

Name Size Download all
md5:61039873a064cfccf46a92a8ca3b57dd
680.4 kB Preview Download

Additional details

Identifiers

DOI
10.54105/ijapsr.E4045.04050824
EISSN
2582-7618

Dates

Accepted
2024-08-15
Manuscript received on 30 June 2024 | Revised Manuscript received on 13 July 2024 | Manuscript Accepted on 15 August 2024 | Manuscript published on 30 August 2024.

References

  • Mishra, R., & Sathyaseelan, B. (2019, January 2). Generic Drug Distribution in India- Issues and Challenges. Journal of Pharmaceutical Care & Health Systems, 06(01), 199. https://doi.org/10.4172/2376-0419.1000199
  • Mahato, T., & Raulji, D. (2021, August 16). Present scenario of generic medicines in India: A comparative study. World Journal of Biology Pharmacy and Health Sciences, 7, 053-059. https://doi.org/ 10.30574/wjbphs.2021.7.2.0086
  • Dixit, A., Kumar, N., Kumar, S. (2019, January 1). Use of Generic Medicines: Challenges and Benefits. Journal of Health Management, 20(1), 1-7. https://doi.org/ 10.1177/097206341774774
  • Junofy, A.R. (2013, September). A Study on Poverty and Hunger in India. Mediterranean Journal of Social Sciences, 4(12), 147-153. https://doi.org/ 10.5901/mjss.2013.v4n12p147
  • Mukherjee, K. (2017, May 1). A Cost Analysis of the Jan Aushadhi Scheme in India. International Journal Health Policy Management, 6(5), 253-256. https://doi.org/ 10.15171/ijhpm.2017.02
  • Lennernas, H., Fager, G. (1997). Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors: similarities and differences. Clin Pharmacokinet, 32(5), 403–425. https://doi.org/ 10.2165/00003088-199732050-00005
  • Illingworth, D., Tobert, J. (2001, February). HMG-CoA reductase inhibitors. Advances in protein chemistry, 56, 77-114. https://doi.org/10.1016/S0065-3233(01)56003-9
  • Balasubramanian, R., Maideen. N. (2021). HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview. Curr Drug Metab, 22(5), 328-341. https://doi.org/ 10.2174/1389200222666210114122729
  • Endo, A., Hasumi, K. (1994). HMG-CoA reductase inhibitors. Natural product reports, 10, 541-50. https://doi.org/10.1039/NP9931000541
  • Mukundan, D., Vasanthakumari, R. (2014). Basic analytical parameters of Atorvastatin Calcium IP (Atroveen-10) granular, compressed, and film-coated tablets. Journal of Biochemical Sciences, 1(1), 39-49.
  • Kogawa, A., Pires, A., Salgado, H. (2019, May 1). Atorvastatin: A Review of Analytical Methods for Pharmaceutical Quality Control and Monitoring. Journal of AOAC International, 102(3), 801-809. https://doi.org/10.5740/jaoacint.18-0200
  • Kundo, N., Dutta, S., Sarker, A., Sultana, C., Haque, M.A., Islam, M.N. (2016). Formulation and Evaluation of Rosuvastatin Immediate Release Tablets 10 Mg. IOSR Journal of Pharmacy and Biological Sciences, 11(05), 01-05. https://doi.org/ 10.9790/3008-1105030105
  • Lamb, Y. (2020, August). Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia. A Journal of Cardiovasc Drugs, 20(4), 381-392. https://doi.org/10.1007/s40256-020-00421-1
  • Parikh, B., Patel, D., Patel, C., Dave, J., Gothi, G., Patel, T. (2010, February). Formulation, optimization, and evaluation of immediate release tablet of telmisartan. Journal of Global Pharma Technology, 2(2), 79-84.
  • Ramu, B., Manasa, M.S. (2015). Formulation and Evaluation of Colon Specific Drug Delivery of Press Coated Lansoprazole Tablets. Indo American Journal of Pharmaceutical Research, 5(4),1522.
  • Tanni, A., Tabassum, S., Mahmud, R., Idris, J., Shahriar, M. (2017). Comparative in vitro analysis of physicochemical properties of some aceclofenac generic tablets marketed in Bangladesh. Journal of Biomedical and Pharmaceutical Research, 6(3), 99-105.
  • Desu, P., Rao, P., Prasanthi, T., Lakshmi, G., Sankar, K., Muneer, S. (2018). Formulation and Evaluation of Immediate Release Tablets of Nevirapine Solid Dispersions. ARC Journal of Pharmaceutical Sciences, 4(3), 13-20. https://doi.org/ 10.20431/2455-1538.0404001
  • Chavan, H., Chhabra, G., Gujarathi, N., Jadhav, A. (2018, July). Comparative study of In-process and finished products quality control test for tablet and capsules according to pharmacopeias. Asian Journal of Pharmaceutical Research and Development. 6(3), 60-68. https://doi.org/10.22270/ajprd.v6i3.370
  • Saleem, M., Shahin, M., Srinivas, B., Begum, A. (2014). Evaluation of tablets by friability apparatus. International Journal of Research in Pharmacy and Chemistry, 4(4),837-840.
  • Maclean, N., Walsh, E., Soundaranathan, M., Khadra, I., Mann, J., Williams, H., Markl, D. (2021, April). Exploring the performance-controlling tablet disintegration mechanisms for direct compression formulations. International Journal of Pharmacy, 599,120221. https://doi.org/ 10.1016/j.ijpharm.2021.120221
  • Bozal-Palabiyik, B., Uslu, B., Ozkan, Y., Ozkan, S. (2018). In-Vitro Drug Dissolution Studies in Medicinal Compounds. Curr Med Chem. 25(33),4020-4036. https://doi.org/ 10.2174/0929867325666180322145335
  • Mohapatra, S., Sahoo, R., Mallick, S., Mohapatra, R. (2021). Enteric Dissolution Enhancement of Engineered Gastro Resistant Omeprazole Tablets using Hydroxypropyl Methylcellulose Acetate Succinate. Indian Journal of Pharmaceutical Education and Research, 55(3), 677-684. https://doi.org/ 10.5530/ijper.55.3.139
  • Kumar, N., Nath, G. (2013, September). Xanthan gum based once a day matrix tablet of cefixime trihydrate: development and evaluation. International Journal of Pharmaceutical Sciences and Research, 4(9), 3390-3399. http://dx.doi.org/10.13040/IJPSR.0975-8232.4(9).3390-99
  • Berthomieu, C., Hienerwadel, R. (2009, August). Fourier transform infrared (FTIR) spectroscopy. Photosynth Res, 101(2-3),157-70. https://doi.org/10.1007/s11120-009-9439-x
  • Noor, S., Salam, F.B., Hima, H.N., Bhuiyan, S., Chowdhury, S. (2017, June). Comparative in-vitro quality evaluation of some brands of metronidazole tablets available in Bangladesh. International Journal of Applied Research and Studies, 3(7),753-758.
  • Dash, S., Murthy, P., Nath, L., Chowdhury, P. (2010, May). Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm.,67(3):217-23.
  • Nanjwade, V., Manvi, F., Nanjwade, B. (2013, March). Formulation and Evaluation of Dispersible Tablets of Lomefloxacin HCl. International Journal of Drug Development and Research, 5(1), 103-113.
  • Gopalkrishnan, Dr. S., Aggarwal, P., & Balabhadra, N. (2019). Developing Synergies in the Pharmaceutical Sector: M&A Activity post 2005. In International Journal of Recent Technology and Engineering (IJRTE) (Vol. 8, Issue 2, pp. 3256–3265). https://doi.org/10.35940/ijrte.b1651.078219
  • Sabitha, B., Akila, K., Radhakrishnan, G. A. A., Krishnan, G. A., & Naveen, S. (2019). Automatic Medicine Vending Machine. In International Journal of Engineering and Advanced Technology (Vol. 9, Issue 2, pp. 1850–1853). https://doi.org/10.35940/ijeat.f7977.129219
  • A Research on Employee Involvement in Pharmaceutical Industry in India. (2019). In International Journal of Innovative Technology and Exploring Engineering (Vol. 8, Issue 6S4, pp. 420–423). https://doi.org/10.35940/ijitee.f1085.0486s419